Usually this happens for a few reasons.
1. Only the subset of transcripts that meet rigorous alignment
validation criteria are used for PASA assembly
2. The quality of the genome matters - if there are gaps resulting in
partial alignments, these won't be included
3. If the input transcript data derive from a de novo assembly, these
could include artifacts (imperfections) that won't impact BUSCO but
would impact genome annotations - related to above 1 and 2.
Probably others too. If you take transcripts that have BUSCO but
aren't included in PASA assemblies, you could delve deeper into
specific examples and their reasons.
hope this helps,
~b
On Wed, Nov 30, 2022 at 10:29 AM Krešimir Križanović
> To view this discussion on the web visit
https://groups.google.com/d/msgid/pasapipeline-users/fb265fc4-9a04-4ee2-a659-daa71180c808n%40googlegroups.com.